No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Jentadueto is a combination drug used to treat type 2 diabetes. It is a combination of two drugs, linagliptin and metformin, which work together to reduce blood sugar levels. The drug is used to improve glycemic control in adults with type 2 diabetes, and is often prescribed in combination with lifestyle changes such as diet and exercise. It is also used to reduce the risk of cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.
Endocrine and Metabolic Disorders Drugs are a class of medications used to treat a variety of conditions related to hormones and metabolism. These drugs are used to treat conditions such as diabetes, thyroid disorders, obesity, and other endocrine and metabolic disorders. They can be used to control blood sugar levels, reduce cholesterol, and regulate hormones.
The Jentadueto market is a subset of the larger Endocrine and Metabolic Disorders Drugs market. It is a growing market, with an increasing number of patients being prescribed the drug.
Some companies in the Jentadueto market include Boehringer Ingelheim, Eli Lilly, Merck, and Novo Nordisk. Show Less Read more
